Delivery Order SPE2DB24D2205-SPE2DB25FEHUB
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $13,637.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $11,862.80, with an ultimate completion date of August 15, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $13,399.76 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive, non-set-aside delivery order carries a ceiling value of $5,838.82 under a firm fixed price arrangement, with an ultimate completion date of September 10, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $4,525.13 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on September 11, 2025, with a completion date of September 12, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a ceiling value of $11,315.12. This is a firm fixed price delivery order with an ultimate completion date of May 13, 2025, and represents a non-set-aside competitive procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a contract ceiling value of $1,961.44. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999.99 billion through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $10,440.57. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and is scheduled for ultimate completion by August 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This contract, valued at $2,396.05, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion on July 15, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHUBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,146.68 and an ultimate completion date of September 19, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and this delivery order falls under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. Ondansetron is an antiemetic medication commonly used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery in military and federal healthcare settings. This delivery order represents routine pharmaceutical replenishment under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to supply a wide range of medications, vaccines, and medical supplies to the Defense Health Agency and other government healthcare systems. The competitively awarded contract demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements for essential pharmaceutical products supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/18/25 |